HeraMED (ASX:HMD) onboarded more than 3,800 expectant mothers onto the HeraCARE maternity monitoring and management platform as of Sept. 30, according to a Tuesday filing with the Australian bourse.
The platform currently reached a new record of 710 expectant mothers, the filing stated.
The medical data and technology company attributed its growth to US-based Broward Health, which added 207 active users in its first 100 days of going live with HeraCARE.
HeraMED's shares were up nearly 5% in recent trade.
Price (AUD): $0.02, Change: $+0.00100, Percent Change: +4.76%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.